These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 21284550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1beta and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis.
    Correa FO, Gonçalves D, Figueredo CM, Gustafsson A, Orrico SR.
    J Periodontol; 2008 Nov; 79(11):2143-50. PubMed ID: 18980523
    [Abstract] [Full Text] [Related]

  • 6. Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes.
    Santos VR, Lima JA, Gonçalves TE, Bastos MF, Figueiredo LC, Shibli JA, Duarte PM.
    J Periodontol; 2010 Oct; 81(10):1455-65. PubMed ID: 20476881
    [Abstract] [Full Text] [Related]

  • 7. Proinflammatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes.
    Venza I, Visalli M, Cucinotta M, De Grazia G, Teti D, Venza M.
    J Periodontol; 2010 Jan; 81(1):99-108. PubMed ID: 20059422
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Emerging roles of Interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease.
    Bozkurt Doğan Ş, Öngöz Dede F, Ballı U, Sertoğlu E.
    Cytokine; 2021 Aug; 144():155584. PubMed ID: 34034144
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
    Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, Atilla G, Hughes FJ, Belibasakis GN.
    J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis.
    Baltacıoğlu E, Kehribar MA, Yuva P, Alver A, Atagün OS, Karabulut E, Akalın FA.
    J Periodontol; 2014 Feb; 85(2):317-26. PubMed ID: 23701481
    [Abstract] [Full Text] [Related]

  • 18. Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease.
    Gümüş P, Buduneli E, Bıyıkoğlu B, Aksu K, Saraç F, Nile C, Lappin D, Buduneli N.
    J Periodontol; 2013 Nov; 84(11):1627-37. PubMed ID: 23327689
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.